We are live on ! Find out more

MACA

Moringa Acquisition Corp Class A Ordinary Shares

MACA

Market cap $32.6M

Delisted

MACA was delisted on the 15th of August, 2024.

Back to rankings

About: Moringa Acquisition Corp is a blank check company.

Employees: 3

Financials Shell Companies

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 0%

Neutral 0%

Negative 0%

Silexion Therapeutics Ltd. and Moringa Acquisition Corp Announce Closing of their Business Combination

The combined company's shares and warrants are expected to begin trading on Nasdaq under the tickers “SLXN” and “SLXNW”, respectively on August 16, 2024 The combined company's shares and warrants are expected to begin trading on Nasdaq under the tickers “SLXN” and “SLXNW”, respectively on August 16, 2024

Silexion Therapeutics Ltd. and Moringa Acquisition Corp Announce Closing of their Business Combination

Silexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp

Moringa Acquisition Corp (Nasdaq: MACA) (“Moringa”), a special purpose acquisition company, today announced it has entered into a business combination agreement with Silexion Ltd. (“Silexion”), a clinical-stage, oncology-focused biotechnology company, that would result in Silexion becoming publicly listed on the Nasdaq. The business combination provides for Silexion's pre-transaction equity value to be $62.5 million, based on a $10 share price.

Silexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp

See News Rankings

Price charts implemented using Lightweight Charts™